Semen DNA fragmentation index, evaluated with both TUNEL and Comet assay, and the ICSI outcome

Gamze Sinem Caglar1, Frank Köster, Beate Schöpper

  • 1Department of Obstetrics and Gynecology, University Clinic of Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, D-23538 Lübeck, Germany.

In Vivo (Athens, Greece)
|January 24, 2008
PubMed
Abstract

Insights

A significant percentage of sperm samples used for intracytoplasmic sperm injection (ICSI) show high DNA fragmentation. However, this DNA fragmentation index (DFI) did not correlate with ICSI treatment success.

Area of Science:

  • Reproductive Medicine
  • Sperm Biology
  • Assisted Reproductive Technologies

Background:

  • Sperm DNA fragmentation poses a risk in intracytoplasmic sperm injection (ICSI).
  • Assessing DNA fragmentation is crucial for optimizing ICSI outcomes.

Purpose of the Study:

  • To determine the prevalence of spermatozoa with DNA fragmentation in ICSI samples.
  • To investigate the correlation between DNA fragmentation index (DFI) and ICSI success rates.

Main Methods:

  • Evaluated DFI in processed semen samples from 56 couples undergoing ICSI.
  • Utilized terminal deoxynucleotidyl transferase-mediated dUDP nick-end labelling (TUNEL) and single cell gel electrophoresis (Comet) assays.

Main Results:

  • 17.85% of processed semen samples exhibited a DFI of >=10%.
  • No significant correlation was found between DFI and ICSI outcomes.
  • TUNEL assay showed DFI negatively correlated with sperm concentration, motility, and morphology.

Conclusions:

  • A substantial portion of semen samples for ICSI have elevated DFI.
  • DFI in processed semen samples does not appear to impact ICSI success.

Related Concept Videos